Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle R Machacek

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Patents|September 14, 2010
Update on lymphocyte specific kinase inhibitors: a patent surveyMatthew W Martin, Michelle R Machacek
Accounts of Chemical Research|October 18, 2006
Predicting the stereochemistry of diphenylphosphino benzoic acid (DPPBA)-based palladium-catalyzed asymmetric allylic alkylation reactions: a working modelBarry M Trost, Michelle R Machacek, Aaron Aponick
Organic Letters|May 24, 2003
Ruthenium-catalyzed vinylsilane synthesis and cross-coupling as a selective approach to alkenes: benzyldimethylsilyl as a robust vinylmetal functionalityBarry M Trost, Michelle R Machacek, Zachary T Ball
Journal of the American Chemical Society|May 12, 2005
Development of aliphatic alcohols as nucleophiles for palladium-catalyzed DYKAT reactions: total synthesis of (+)-hippospongic acid ABarry M Trost, Michelle R Machacek, Hong C Tsui
Journal of the American Chemical Society|May 18, 2006
Sequential Ru-Pd catalysis: a two-catalyst one-pot protocol for the synthesis of N- and O-heterocyclesBarry M Trost, Michelle R Machacek, Brian D Faulk
Chembiochem : a European Journal of Chemical Biology|February 1, 2022
NMR Data-Driven Docking of HDM2-Inhibitor ComplexesXavier Fradera, Michael H Reutershan, Michelle R Machacek, et al.
Bioorganic & Medicinal Chemistry|May 20, 2022
Design and synthesis of unprecedented 9- and 10-membered cyclonucleosides with PRMT5 inhibitory activityShuhei Kawamura, Rachel L Palte, Hai-Young Kim, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)Rachel L Palte, Sebastian E Schneider, Michael D Altman, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 InhibitorsChunhui Huang, Christian Fischer, Michelle R Machacek, et al.
Journal of Medicinal Chemistry|October 29, 2021
Discovery of <b>MK-4688</b>: an Efficient Inhibitor of the HDM2-p53 Protein-Protein InteractionMichael H Reutershan, Michelle R Machacek, Michael D Altman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|September 14, 2010
Update on lymphocyte specific kinase inhibitors: a patent surveyMatthew W Martin, Michelle R Machacek
Accounts of Chemical Research|October 18, 2006
Predicting the stereochemistry of diphenylphosphino benzoic acid (DPPBA)-based palladium-catalyzed asymmetric allylic alkylation reactions: a working modelBarry M Trost, Michelle R Machacek, Aaron Aponick
Organic Letters|May 24, 2003
Ruthenium-catalyzed vinylsilane synthesis and cross-coupling as a selective approach to alkenes: benzyldimethylsilyl as a robust vinylmetal functionalityBarry M Trost, Michelle R Machacek, Zachary T Ball
Journal of the American Chemical Society|May 12, 2005
Development of aliphatic alcohols as nucleophiles for palladium-catalyzed DYKAT reactions: total synthesis of (+)-hippospongic acid ABarry M Trost, Michelle R Machacek, Hong C Tsui
Journal of the American Chemical Society|May 18, 2006
Sequential Ru-Pd catalysis: a two-catalyst one-pot protocol for the synthesis of N- and O-heterocyclesBarry M Trost, Michelle R Machacek, Brian D Faulk
Chembiochem : a European Journal of Chemical Biology|February 1, 2022
NMR Data-Driven Docking of HDM2-Inhibitor ComplexesXavier Fradera, Michael H Reutershan, Michelle R Machacek, et al.
Bioorganic & Medicinal Chemistry|May 20, 2022
Design and synthesis of unprecedented 9- and 10-membered cyclonucleosides with PRMT5 inhibitory activityShuhei Kawamura, Rachel L Palte, Hai-Young Kim, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)Rachel L Palte, Sebastian E Schneider, Michael D Altman, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 InhibitorsChunhui Huang, Christian Fischer, Michelle R Machacek, et al.
Journal of Medicinal Chemistry|October 29, 2021
Discovery of <b>MK-4688</b>: an Efficient Inhibitor of the HDM2-p53 Protein-Protein InteractionMichael H Reutershan, Michelle R Machacek, Michael D Altman, et al.
Pageof 2